Koninklijke Philips (PHG) Net Income towards Common Stockholders (2009 - 2026)
Koninklijke Philips (PHG) posted quarterly Net Income towards Common Stockholders of $446.3 million for Q2 2026, up 64.3% year-over-year from $271.7 million in Q2 2025, and up 152.48% quarter-over-quarter from $176.8 million in Q1 2026.
Koninklijke Philips (PHG) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Koninklijke Philips' Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at $446.3 million for Q2 2026.
- In Q2 2026, Net Income towards Common Stockholders rose 64.3% year-over-year to $446.3 million; the TTM figure through Jun 2026 stood at $1.7 billion (up 761.82% YoY), while the FY2025 annual figure was $1.0 billion, up 238.88% from the prior year.
- Net Income towards Common Stockholders for Q2 2026 stood at $446.3 million, up from $176.8 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $584.5 million in Q3 2025, with the low at -$356.9 million in Q4 2024.
- The 5-year median for Net Income towards Common Stockholders is -$73879.9 (2022), against an average of $130.0 million.
- Peak annual rise in Net Income towards Common Stockholders reached 69789.8% in 2024, while the deepest fall reached 829400.18% in 2024.
- Koninklijke Philips' Net Income towards Common Stockholders stood at -$1.8 million in 2022, then jumped by 102.4% to $43037.6 in 2023, then plunged by 829400.18% to -$356.9 million in 2024, then jumped by 228.83% to $459.8 million in 2025, then decreased by 2.93% to $446.3 million in 2026.
- Business Quant data shows PHG's Net Income towards Common Stockholders at $446.3 million in Q2 2026, $176.8 million in Q1 2026, and $459.8 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.09 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.82 Bn | 126.34 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.34 Bn | 111.12 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.41 Bn | 73.88 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 52.56 Bn | 48.31 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.76 Bn | 32.82 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.84 Bn | 31.73 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Zimmer Biomet Holdings | 19.42 Bn | 19.01 Bn | 1.54 Bn | 199.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 446.35 Mn |
| Mar 31, 2026 | 176.78 Mn |
| Dec 31, 2025 | 459.80 Mn |
| Sep 30, 2025 | 584.53 Mn |
| Jun 30, 2025 | 271.67 Mn |
| Mar 31, 2025 | 79.94 Mn |
| Dec 31, 2024 | -356.91 Mn |
| Sep 30, 2024 | 198.78 Mn |
| Jun 30, 2024 | 485.68 Mn |
| Mar 31, 2024 | -1.19 Mn |
| Dec 31, 2023 | 43,037.60 |
| Sep 30, 2023 | -587,838.86 |
| Jun 30, 2023 | -696,911.61 |
| Mar 31, 2023 | -772,806.11 |
| Dec 31, 2022 | -1.80 Mn |
| Sep 30, 2022 | -1.65 Mn |
| Jun 30, 2022 | -202,740.77 |
| Mar 31, 2022 | -190,797.41 |
| Dec 31, 2021 | 766,460.54 |
| Sep 30, 2021 | 601,436.53 |